Diclofenac: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In pharmacology, diclofenac is "non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt."<ref>{{MeSH}...) |
mNo edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[pharmacology]], [[diclofenac]] is "[[non-steroidal anti-inflammatory agent]] (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt."<ref>{{MeSH}}</ref> | In [[pharmacology]], [[diclofenac]] is "[[non-steroidal anti-inflammatory agent]] (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt."<ref>{{MeSH}}</ref> | ||
==Adverse effects== | |||
===Vascular disease=== | |||
NSAIDs, especially [[diclofenac]], may cause recurrence of [[vascular disease]] among patients with prior [[myocardial infarction]]s.<ref name="pmid21555710">{{cite journal| author=Schjerning Olsen AM, Fosbøl EL, Lindhardsen J, Folke F, Charlot M, Selmer C et al.| title=Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study. | journal=Circulation | year= 2011 | volume= 123 | issue= 20 | pages= 2226-35 | pmid=21555710 | doi=10.1161/CIRCULATIONAHA.110.004671 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21555710 }} </ref> | |||
==References== | ==References== | ||
| Line 5: | Line 10: | ||
==External links== | ==External links== | ||
{{CZMed}} | {{CZMed}}[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 06:00, 7 August 2024
In pharmacology, diclofenac is "non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt."[1]
Adverse effects
Vascular disease
NSAIDs, especially diclofenac, may cause recurrence of vascular disease among patients with prior myocardial infarctions.[2]
References
- ↑ Anonymous (2024), Diclofenac (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Schjerning Olsen AM, Fosbøl EL, Lindhardsen J, Folke F, Charlot M, Selmer C et al. (2011). "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.". Circulation 123 (20): 2226-35. DOI:10.1161/CIRCULATIONAHA.110.004671. PMID 21555710. Research Blogging.
External links
The most up-to-date information about Diclofenac and other drugs can be found at the following sites.
- Diclofenac - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Diclofenac - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Diclofenac - Detailed information from DrugBank.